Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) Trial: A Multi-Center Registry Study Assessing Transplanted Kidney Status

NCT07551531 is registered in ClinicalTrials.gov with Insight Molecular Diagnostics as lead sponsor.

NCT NCT07551531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07551531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) Trial: A Multi-Center Registry Study Assessing Transplanted Kidney Status
Lead sponsor
Insight Molecular Diagnostics
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
June 30, 2033
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant